1.4200 -0.10 (-6.58%)
After hours: 5:23PM EST
|Bid||1.4200 x 1000|
|Ask||1.6100 x 900|
|Day's Range||1.4200 - 1.6065|
|52 Week Range||0.3700 - 2.2000|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||3.62|
|Earnings Date||May 16, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.07|
Dunxin Financial Holdings Limited ("Dunxin" or the "Company" NYSE American: DXF), a licensed microfinance lender serving individuals and small and medium enterprises (SMEs) in Hubei Province, China, today announced that the Company signed an Intentional Cooperation Agreement with Baite Biological Group Co., Ltd. The Company and Baite Biological Group plan to carry out cooperation in market expansion and production research and development in three aspects: (1) In Vitro Diagnostic industry, (2) hospital intelligent laboratory, (3) production and manufacturing of high-end medical devices.
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (NYSE American: DXF), a leading licensed microfinance lender serving individuals and small and medium enterprises (SMEs) in Hubei Province, China, today announced its unaudited financial results for the first six months of 2019. The unaudited consolidated financial statements and other financial information included in this press release have been prepared in conformity with International Financial Reporting Standards ("IFRS") and stated in Renminbi ("RMB") unless otherwise indicated.